SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-050609
Filing Date
2023-11-01
Accepted
2023-11-01 06:07:06
Documents
2
Period of Report
2023-10-30

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1430
2 EXHIBIT 24 ef20013815_ex24.htm EX-24 7766
  Complete submission text file 0001140361-23-050609.txt   10688
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130 650-266-8674
GYRE THERAPEUTICS, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12730 HIGH BLUFF DRIVE SUITE 250 SAN DIEGO CA 92130
Business Address
Carmichael Gordon (Reporting) CIK: 0001982077 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 231366426